a further aspect of the invention pertains to treating an NNMT-expressing cancer, such as glioblastoma, by administering a therapeutically effective amount of one or more cations chosen from Tables 3a and 3b followed by the administration of one or more cations of the invention
Aqua/Water/Eau, Citrus Aurantium Dulcis (Orange) Flower Water, Tocopheryl Acetate, Ferulic Acid, Lactic Acid, Ascorbic Acid , Oryza Sativa (Rice) Callus Culture Extract, Bifida Ferment Lysate, Salix Alba (Willow) Bark Extract , Caprylic/Capric Triglyceride, Hydrogenated Polydecene, Glycerin, Propanediol, Glyceryl Stearate, Cetearyl Alcohol, Sorbitan Stearate, Polysorbate 60, Palmitic Acid, Stearic Acid, Betaine, Phenoxyethanol, Citrus Aurantium Dulcis (Orange) Peel Oil, Citrus Grandis (Grapefruit) Peel Oil, Olea Europaea (Olive) Fruit Oil, Citrus Limon (Lemon) Peel Oil, Litsea Cubeba Fruit Oil, Carbomer, Arginine, Sodium Hyaluronate, Allantoin , Ethylhexylglycerin, Disodium EDTA, 1,2-Hexanediol, Pentylene Glycol, Butylene Glycol, Caprylyl Glycol Pixi based the Vitamin-C Lotion on the same solutions as the rest of Vitamin-C series
All analyses were two-sided and performed using R software (Version 4.0.2) with the TwosampleMR and MR-PRESSO R packages
After another course of ATO (0.16mgkg -1 d -1 ) and ATRA (25mgm -2 d -1 ), the PML-RARA fusion gene turned negative, and the patient achieved complete remission (CR)
Disclosures: Chun-Ming Hong: Nothing to Disclose, Chih-Horng Wu: Nothing to Disclose, Tung-Hung Su: Nothing to Disclose, Shih-Jer Hsu: Nothing to Disclose, Tai-Chung Tseng: Nothing to Disclose, Chen-Hua Liu: Nothing to Disclose, Hung-Chih Yang: Nothing to Disclose, Jia-Horng Kao: Nothing to Disclose, Pei-Jer Chen: Nothing to Disclose, Shang-Chin Huang: Nothing to Disclose, Chun Jen Liu: Nothing to Disclose 1793 RESVERATROL AND TANSHINONE IIA SYNERGIZE TO SUPPRESS HEPATOCELLULAR CARCINOMA BY MODULATING STROMAL CELLS TO REMODEL TUMOR MICROENVIRONMENT Jia Shi 1 Xuemei Zhang 1 Xiaona Lu 1 Shihan Yu 1 Wenlan Zheng 1 Hai Feng 1 Zhuo Yu 2 , 1 Shuguang hospital Affiliated to SHUTCM, 2 Shuguang Hospital Affiliated to Shanghai University of TCM Background: Hepatocellular carcinoma (HCC) is usually insensitive to immunotherapy due to the aggravated immunosuppressive statue in context of liver fibrosis
"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis"
